Salarius Pharmaceuticals Ownership 2024 | Who Owns Salarius Pharmaceuticals Now?

OverviewFinancials Chart

Institutional Ownership

6.11%

Insider Ownership

2.52%

Retail Ownership

91.37%

Institutional Holders

18.00

Salarius Pharmaceuticals Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
HORIZON KINETICS ASSET MANAGEMENT LLC	1.53%	0.00%	32,400	32,400	100.00%	61,884,000	Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC	0.94%	0.00%	20,042	3,700	22.64%	38,000	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	0.78%	-	16,523	-	-	31,724,000	Mar 31, 2023
VANGUARD GROUP INC	0.73%	-	15,420	-22,734	-59.58%	29,452,000	Mar 31, 2023
TWO SIGMA INVESTMENTS, LP	0.49%	0.00%	10,370	10,370	100.00%	19,807,000	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	0.07%	-	1,387	80	6.12%	2,649,000	Mar 31, 2023
UBS GROUP AG	0.05%	-	1,126	887	371.13%	2,151,000	Mar 31, 2023
MORGAN STANLEY	0.00%	-	60	-3	-4.76%	115,000	Mar 31, 2023
FMR LLC	0.00%	-	47	47	100.00%	90,000	Mar 31, 2023
BLACKROCK INC.	0.00%	-	47	-	-	90,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.00%	-	15	-	-	29,000	Mar 31, 2023

Salarius Pharmaceuticals's largest institutional shareholder is HORIZON KINETICS ASSET MANAGEMENT LLC, holding 1.53% of the company's total share outstanding, currently valued at $61.88M. The top 10 institutional shareholders own together 4.59% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
HORIZON KINETICS ASSET MANAGEMENT LLC	1.53%	0.00%	32,400	32,400	100.00%	61,884,000	Mar 31, 2023
TWO SIGMA INVESTMENTS, LP	0.49%	0.00%	10,370	10,370	100.00%	19,807,000	Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC	0.94%	0.00%	20,042	3,700	22.64%	38,000	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	0.07%	-	1,387	80	6.12%	2,649,000	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	0.78%	-	16,523	-	-	31,724,000	Mar 31, 2023
UBS GROUP AG	0.05%	-	1,126	887	371.13%	2,151,000	Mar 31, 2023
VANGUARD GROUP INC	0.73%	-	15,420	-22,734	-59.58%	29,452,000	Mar 31, 2023
MORGAN STANLEY	0.00%	-	60	-3	-4.76%	115,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.00%	-	15	-	-	29,000	Mar 31, 2023
FMR LLC	0.00%	-	47	47	100.00%	90,000	Mar 31, 2023
BLACKROCK INC.	0.00%	-	47	-	-	90,000	Mar 31, 2023

The largest Salarius Pharmaceuticals shareholder by % of total assets is HORIZON KINETICS ASSET MANAGEMENT LLC. The company owns 32.40K shares of Salarius Pharmaceuticals (SLRX), representing 0.00% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
HORIZON KINETICS ASSET MANAGEMENT LLC	1.53%	0.00%	32,400	32,400	100.00%	61,884,000	Mar 31, 2023
TWO SIGMA INVESTMENTS, LP	0.49%	0.00%	10,370	10,370	100.00%	19,807,000	Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC	0.94%	0.00%	20,042	3,700	22.64%	38,000	Mar 31, 2023
UBS GROUP AG	0.05%	-	1,126	887	371.13%	2,151,000	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	0.07%	-	1,387	80	6.12%	2,649,000	Mar 31, 2023
FMR LLC	0.00%	-	47	47	100.00%	90,000	Mar 31, 2023
BLACKROCK INC.	0.00%	-	47	-	-	90,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.00%	-	15	-	-	29,000	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	0.78%	-	16,523	-	-	31,724,000	Mar 31, 2023
MORGAN STANLEY	0.00%	-	60	-3	-4.76%	115,000	Mar 31, 2023
VANGUARD GROUP INC	0.73%	-	15,420	-22,734	-59.58%	29,452,000	Mar 31, 2023

As of Mar 31 2023, Salarius Pharmaceuticals's largest institutional buyer is HORIZON KINETICS ASSET MANAGEMENT LLC. The company purchased 32.40K stocks of SLRX, valued at $61.88M.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
VANGUARD GROUP INC	0.73%	-	15,420	-22,734	-59.58%	29,452,000	Mar 31, 2023
MORGAN STANLEY	0.00%	-	60	-3	-4.76%	115,000	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	0.78%	-	16,523	-	-	31,724,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.00%	-	15	-	-	29,000	Mar 31, 2023
BLACKROCK INC.	0.00%	-	47	-	-	90,000	Mar 31, 2023
FMR LLC	0.00%	-	47	47	100.00%	90,000	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	0.07%	-	1,387	80	6.12%	2,649,000	Mar 31, 2023
UBS GROUP AG	0.05%	-	1,126	887	371.13%	2,151,000	Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC	0.94%	0.00%	20,042	3,700	22.64%	38,000	Mar 31, 2023
TWO SIGMA INVESTMENTS, LP	0.49%	0.00%	10,370	10,370	100.00%	19,807,000	Mar 31, 2023
HORIZON KINETICS ASSET MANAGEMENT LLC	1.53%	0.00%	32,400	32,400	100.00%	61,884,000	Mar 31, 2023

As of Mar 31 2023, Salarius Pharmaceuticals's biggest institutional seller is VANGUARD GROUP INC. The company sold -22.73K shares of SLRX, valued at $29.45M.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
HORIZON KINETICS ASSET MANAGEMENT LLC	1.53%	0.00%	32,400	32,400	100.00%	61,884,000	Mar 31, 2023
TWO SIGMA INVESTMENTS, LP	0.49%	0.00%	10,370	10,370	100.00%	19,807,000	Mar 31, 2023
FMR LLC	0.00%	-	47	47	100.00%	90,000	Mar 31, 2023

Salarius Pharmaceuticals's largest new institutional shareholder by number of shares is HORIZON KINETICS ASSET MANAGEMENT LLC, purchased 32.40K shares, valued at $61.88M, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date

Salarius Pharmaceuticals Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
KINETICS PORTFOLIOS TRUST	0.03%	60,000	-	-	Mar 31, 2024
Listed Funds Trust	0.01%	31,094	-	-	Mar 31, 2024
VANGUARD INDEX FUNDS	0.00%	1,231,419	-	-	Mar 31, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS	0.00%	61,728	-	-	Mar 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	373,138	-	-	Feb 29, 2024
KINETICS PORTFOLIOS TRUST	0.00%	2,400	-	-	Mar 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	23,411	-	-	Feb 29, 2024
Blackstone Alternative Investment Funds	0.00%	6,300	-	-	Mar 31, 2023
DFA INVESTMENT DIMENSIONS GROUP INC	0.00%	53,935	-	-	Jan 31, 2024
VANGUARD INDEX FUNDS	0.00%	14,563	-14,563	-50.00%	Mar 31, 2024
USAA MUTUAL FUNDS TRUST	0.00%	6,064	-	-	Jan 31, 2024
EQ ADVISORS TRUST	0.00%	9,363	-	-	Mar 31, 2024
Dimensional ETF Trust	0.00%	430	-	-	Jan 31, 2024
Blackstone Alternative Investment Funds	0.00%	44	44	-	Mar 31, 2023

Salarius Pharmaceuticals's largest mutual fund holder by % of total assets is "KINETICS PORTFOLIOS TRUST", owning 60.00K shares, compromising 0.03% of its total assets.

Salarius Pharmaceuticals Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
30 Sep, 22	18	-18.18%
30 Jun, 22	22	-8.33%
31 Mar, 22	24	4.35%
31 Dec, 21	23	-8.00%
30 Sep, 21	25	-13.79%
30 Jun, 21	29	-6.45%
31 Mar, 21	31	29.17%
31 Dec, 20	24	41.18%
30 Sep, 20	17	30.77%
30 Jun, 20	13	-18.75%
31 Mar, 20	16	33.33%
31 Dec, 19	12	-
30 Sep, 19	12	-

As of 30 Sep 22, 18 institutions are holding Salarius Pharmaceuticals's shares, representing a decrease of -18.18% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
30 Sep, 22	3,433,223	-16.00%
30 Jun, 22	4,087,188	12.60%
31 Mar, 22	3,629,796	-31.49%
31 Dec, 21	5,298,252	-21.04%
30 Sep, 21	6,709,810	-33.66%
30 Jun, 21	10,114,819	-34.66%
31 Mar, 21	15,480,704	263.13%
31 Dec, 20	4,263,091	470.47%
30 Sep, 20	747,299	54.66%
30 Jun, 20	483,195	-38.09%
31 Mar, 20	780,436	250.22%
31 Dec, 19	222,842	-13.01%
30 Sep, 19	256,178	-

Salarius Pharmaceuticals (SLRX) has 3.43M shares outstanding as of 30 Sep 22, down -16.00% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
30 Sep, 22	6.11%	10.48%
30 Jun, 22	7.64%	12.40%
31 Mar, 22	7.85%	5.72%
31 Dec, 21	11.71%	5.22%
30 Sep, 21	14.98%	2.93%
30 Jun, 21	22.60%	0.88%
31 Mar, 21	50.67%	6.77%
31 Dec, 20	27.36%	158.21%
30 Sep, 20	4.16%	34.67%
30 Jun, 20	3.46%	5.17%
31 Mar, 20	8.19%	149.85%
31 Dec, 19	2.34%	32.38%
30 Sep, 19	2.69%	-

As of 30 Sep 22, Salarius Pharmaceuticals is held by 6.11% institutional shareholders, representing a 10.48% growth compared to 30 Jun 22.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
30 Sep, 22	2	-81.82%
30 Jun, 22	11	22.22%
31 Mar, 22	9	-
31 Dec, 21	9	-35.71%
30 Sep, 21	14	7.69%
30 Jun, 21	13	-48.00%
31 Mar, 21	25	108.33%
31 Dec, 20	12	50.00%
30 Sep, 20	8	166.67%
30 Jun, 20	3	-62.50%
31 Mar, 20	8	100.00%
31 Dec, 19	4	-66.67%
30 Sep, 19	12	-

2 institutional shareholders have increased their position in SLRX stock as of 30 Sep 22 compared to 11 in the previous quarter (a -81.82% decrease).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
30 Sep, 22	7	133.33%
30 Jun, 22	3	-25.00%
31 Mar, 22	4	-33.33%
31 Dec, 21	6	100.00%
30 Sep, 21	3	-66.67%
30 Jun, 21	9	800.00%
31 Mar, 21	1	-66.67%
31 Dec, 20	3	50.00%
30 Sep, 20	2	-33.33%
30 Jun, 20	3	-
31 Mar, 20	-	-100.00%
31 Dec, 19	4	-
30 Sep, 19	-	-

7 institutional shareholders have reduced their position in SLRX stock as of 30 Sep 22 compared to 3 in the previous quarter (a 133.33% increase).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
30 Sep, 22	18	-18.18%	3,433,223	-16.00%	6.11%	10.48%	2	-81.82%	7	133.33%
30 Jun, 22	22	-8.33%	4,087,188	12.60%	7.64%	12.40%	11	22.22%	3	-25.00%
31 Mar, 22	24	4.35%	3,629,796	-31.49%	7.85%	5.72%	9	-	4	-33.33%
31 Dec, 21	23	-8.00%	5,298,252	-21.04%	11.71%	5.22%	9	-35.71%	6	100.00%
30 Sep, 21	25	-13.79%	6,709,810	-33.66%	14.98%	2.93%	14	7.69%	3	-66.67%
30 Jun, 21	29	-6.45%	10,114,819	-34.66%	22.60%	0.88%	13	-48.00%	9	800.00%
31 Mar, 21	31	29.17%	15,480,704	263.13%	50.67%	6.77%	25	108.33%	1	-66.67%
31 Dec, 20	24	41.18%	4,263,091	470.47%	27.36%	158.21%	12	50.00%	3	50.00%
30 Sep, 20	17	30.77%	747,299	54.66%	4.16%	34.67%	8	166.67%	2	-33.33%
30 Jun, 20	13	-18.75%	483,195	-38.09%	3.46%	5.17%	3	-62.50%	3	-
31 Mar, 20	16	33.33%	780,436	250.22%	8.19%	149.85%	8	100.00%	-	-100.00%
31 Dec, 19	12	-	222,842	-13.01%	2.34%	32.38%	4	-66.67%	4	-
30 Sep, 19	12	-	256,178	-	2.69%	-	12	-	-	-

Salarius Pharmaceuticals Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Apr 12, 2024	Arthur David J.	director, officer	Chief Executive Officer	A-Award	Buy	20,500	$0.51	$10.46K	20,500
Feb 22, 2024	Rosenblum Mark J	officer	Exec VP Finance, CFO	A-Award	Buy	22,500	$0.57	$12.85K	22,500
Feb 22, 2024	McVicar William K.	director	-	A-Award	Buy	20,500	$0.57	$11.71K	20,500
Feb 22, 2024	McCreedy Bruce J Jr.	director	-	A-Award	Buy	20,500	$0.57	$11.71K	20,500
Feb 22, 2024	Lieber Jonathan I	director	-	A-Award	Buy	20,500	$0.57	$11.71K	20,500
Feb 22, 2024	Lammers Paul	director	-	A-Award	Buy	20,500	$0.57	$11.71K	20,500
Feb 22, 2024	Burleson Tess	director	-	A-Award	Buy	20,500	$0.57	$11.71K	20,500
Feb 22, 2024	HANISH ARNOLD C	director	-	A-Award	Buy	20,500	$0.57	$11.71K	20,500
Feb 15, 2023	Rosenblum Mark J	officer	Exec VP Finance, CFO	A-Award	Buy	6,432	-	-	21,851
Feb 15, 2023	Arthur David J.	director, officer	Chief Executive Officer	A-Award	Buy	14,300	-	-	48,019
Jan 05, 2023	Lieber Jonathan I	director	-	A-Award	Buy	1,440	-	-	2,940
Jan 05, 2023	McCreedy Bruce J Jr.	director	-	A-Award	Buy	1,440	-	-	1,788
Jan 05, 2023	HANISH ARNOLD C	director	-	A-Award	Buy	1,440	-	-	1,440
Jan 05, 2023	Lammers Paul	director	-	A-Award	Buy	1,440	-	-	1,718
Jan 05, 2023	Burleson Tess	director	-	A-Award	Buy	1,440	-	-	2,722
Jan 05, 2023	McVicar William K.	director	-	A-Award	Buy	1,440	-	-	1,788
Jan 05, 2023	Rosenblum Mark J	officer	Exec VP Finance, CFO	A-Award	Buy	8,000	-	-	15,419
Jan 05, 2023	Arthur David J.	officer	Chief Executive Officer	A-Award	Buy	20,000	-	-	33,719
Dec 12, 2022	Arthur David J.	officer	Chief Executive Officer	A-Award	Buy	2,693	$1.73	$4.67K	13,719
Dec 12, 2022	Rosenblum Mark J	officer	Exec VP Finance, CFO	A-Award	Buy	1,488	$1.73	$2.58K	7,419

Salarius Pharmaceuticals Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2024	1	-	-
Q1 2024	7	-	-
Q1 2023	10	-	-
Q4 2022	6	-	-
Q2 2022	12	-	-
Q1 2022	10	-	-
Q4 2021	2	-	-
Q3 2021	3	-	-
Q2 2021	2	-	-
Q4 2020	10	-	-
Q3 2020	8	-	-
Q2 2020	-	-	-
Q1 2020	24	-	-
Q4 2019	3	-	-
Q3 2019	10	6	166.67%
Q1 2019	-	2	-
Q4 2018	-	3	-
Q3 2018	5	-	-
Q2 2018	2	-	-
Q1 2018	4	-	-

1 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Salarius Pharmaceuticals's insiders, as of Q2 2024.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2024	-	-	-
Q1 2024	-	-	-
Q1 2023	-	-	-
Q4 2022	-	-	-
Q2 2022	10	-	-
Q1 2022	2	-	-
Q4 2021	-	-	-
Q3 2021	3	-	-
Q2 2021	-	-	-
Q4 2020	-	-	-
Q3 2020	5	-	-
Q2 2020	-	-	-
Q1 2020	16	-	-
Q4 2019	3	-	-
Q3 2019	-	-	-
Q1 2019	-	2	-
Q4 2018	-	2	-
Q3 2018	-	-	-
Q2 2018	-	-	-
Q1 2018	-	-	-

As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Salarius Pharmaceuticals's stocks.

Salarius Pharmaceuticals Peer Ownership

Ticker	Company
GOVX	GeoVax Labs, Inc.
MGTA	Dianthus Therapeutics, Inc.
NTRB	Nutriband Inc.
FRTX	Fresh Tracks Therapeutics, Inc.
AXLA	Axcella Health Inc.
MREO	Mereo BioPharma Group plc
HSTO	Histogen Inc.
SABS	SAB Biotherapeutics, Inc.
ARTL	Artelo Biosciences, Inc.
CRVS	Corvus Pharmaceuticals, Inc.
FWBI	Entero Therapeutics, Inc.
AKTX	Akari Therapeutics, Plc
VCNX	Vaccinex, Inc.
AFMD	Affimed N.V.
PIRS	Pieris Pharmaceuticals, Inc.
ALRN	Aileron Therapeutics, Inc.

SLRX Ownership FAQ

Who Owns Salarius Pharmaceuticals?

Salarius Pharmaceuticals is owned by institutional shareholders (6.11%), insiders (2.52%), and public (91.37%). The largest institutional shareholder of Salarius Pharmaceuticals is HORIZON KINETICS ASSET MANAGEMENT LLC (1.53% of total shares) and the top mutual fund owner is KINETICS PORTFOLIOS TRUST (0.03% of total shares).

Who are the major institutional shareholders of Salarius Pharmaceuticals?

Salarius Pharmaceuticals's major institutional shareholders are HORIZON KINETICS ASSET MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, and TWO SIGMA INVESTMENTS, LP. The top five shareholders own together 4.46% of the company's share outstanding.

How many Salarius Pharmaceuticals shareholders are there?

As of Sep 2022, there are 18 institutional shareholders of Salarius Pharmaceuticals.

What percentage of Salarius Pharmaceuticals is owned by HORIZON KINETICS ASSET MANAGEMENT LLC?

HORIZON KINETICS ASSET MANAGEMENT LLC owns 32.4K shares of Salarius Pharmaceuticals, representing 1.53% of the company's total shares outstanding, valued at $61.88M (as of Mar 2023).

What percentage of Salarius Pharmaceuticals is owned by RENAISSANCE TECHNOLOGIES LLC?

As of Mar 2023, RENAISSANCE TECHNOLOGIES LLC holds 20.04K shares of Salarius Pharmaceuticals (SLRX), compromising 0.94% of the company, valued at $38K.

What percentage of Salarius Pharmaceuticals is owned by GEODE CAPITAL MANAGEMENT, LLC?

GEODE CAPITAL MANAGEMENT, LLC is the third largest holder of Salarius Pharmaceuticals. The company owns 16.52K of the company's shares outstanding (worth $31.72M).